Form 8-K - Current report:
SEC Accession No. 0001104659-20-043411
Filing Date
2020-04-06
Accepted
2020-04-06 08:12:13
Documents
3
Period of Report
2020-04-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2015063-1_8k.htm 8-K 19025
2 EXHIBIT 99.1 tm2015063d1_ex99-1.htm EX-99.1 55205
3 GRAPHIC tm2015063d1_ex99-1img001.jpg GRAPHIC 2502
  Complete submission text file 0001104659-20-043411.txt   79062
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 20775795
SIC: 2834 Pharmaceutical Preparations